University of Texas Southwestern Medical Center: Heart Failure trials
The registry lists 23 Heart Failure studies with University of Texas Southwestern Medical Center as lead sponsor. 7 are open to participants now and 3 have results posted.
Phase 1 1Phase 2 4Phase 3 2Phase 4 3No phase 14(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Importance of Point-of-Care Ultrasound for Early Detection of Valvular and Cardiac Diseases (IMPROVE)Not yet recruitingNCT07756398Not applicable
- Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart FailureNot yet recruitingNCT07018297Phase 3
- IEEM-Heat and Heart FailureRecruitingNCT06961929Not applicable
- NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM StudyRecruitingNCT06593327Not applicable
- Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 DiabetesRecruitingNCT06593314Not applicable
- Home-based Cardiac Rehabilitation in Heart FailureRecruitingNCT06349941Phase 3
- Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and InflammationRecruitingNCT06130059Phase 2
- Furoscix in Heart Failure Patients With Diuretic ResistanceCompletedNCT05528588Phase 2Results posted
- Chronotropic Incompetence in Patients With HFpEFCompletedNCT02524145Not applicableResults posted
- Safety and Efficacy Trial to Treat Diastolic Heart Failure Using AmbrisentanTerminatedNCT00840463Phase 4Results posted
- Food Supplementation Delivered Conditionally vs Not Among Patients With Heart FailureCompletedNCT06115369Not applicable
- Digital Remote Home Monitoring for Heart FailureTerminatedNCT05988749Not applicable
- Impact of Empagliflozin on Functional Capacity in Heart Failure with Preserved Ejection FractionCompletedNCT05139472Phase 4
- Efficacy of an m-Health Cardiac Rehabilitation Program in Heart Failure With Preserved Ejection FractionCompletedNCT05002075Not applicable
- Electronic Alerts for Heart Failure Prevention in DiabetesCompletedNCT04791826Not applicable
- Polypill Strategy for Heart Failure With Reduced Ejection FractionCompletedNCT04633005Phase 2
- Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection FractionCompletedNCT04068844Not applicable
- UTSW HP [13-C] Pyruvate Injection in HCMCompletedNCT03057002
- Acute Kidney Injury Genomics and Biomarkers in TAVR StudyCompletedNCT02791880
- Study of the Acute Effects of Triheptanoin in Heart FailureWithdrawnNCT01787851Phase 1/2
- Prevalence of Atrial Delay That Would Preclude Optimization of Atrioventricular (AV) Delay in Patients With Biventricular (BiV) DeviceWithdrawnNCT00906100
- Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency DepartmentCompletedNCT00559338Phase 4
- Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study CohortCompletedNCT00344903